IL87566A0 - Medical composition for the treatment of diabetes comprising a benzamide derivative - Google Patents

Medical composition for the treatment of diabetes comprising a benzamide derivative

Info

Publication number
IL87566A0
IL87566A0 IL87566A IL8756688A IL87566A0 IL 87566 A0 IL87566 A0 IL 87566A0 IL 87566 A IL87566 A IL 87566A IL 8756688 A IL8756688 A IL 8756688A IL 87566 A0 IL87566 A0 IL 87566A0
Authority
IL
Israel
Prior art keywords
treatment
diabetes
medical composition
benzamide derivative
benzamide
Prior art date
Application number
IL87566A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL87566A0 publication Critical patent/IL87566A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
IL87566A 1987-09-01 1988-08-25 Medical composition for the treatment of diabetes comprising a benzamide derivative IL87566A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873729209 DE3729209A1 (de) 1987-09-01 1987-09-01 Verwendung von bezafibrat zur behandlung von diabetes

Publications (1)

Publication Number Publication Date
IL87566A0 true IL87566A0 (en) 1989-01-31

Family

ID=6334986

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87566A IL87566A0 (en) 1987-09-01 1988-08-25 Medical composition for the treatment of diabetes comprising a benzamide derivative

Country Status (16)

Country Link
US (1) US5304575A (fr)
EP (1) EP0305890B1 (fr)
JP (1) JP2647918B2 (fr)
KR (1) KR890004690A (fr)
AT (1) ATE95694T1 (fr)
AU (1) AU610228B2 (fr)
CA (1) CA1323575C (fr)
DE (2) DE3729209A1 (fr)
DK (1) DK472688A (fr)
ES (1) ES2059457T3 (fr)
HU (1) HU200687B (fr)
IE (1) IE62189B1 (fr)
IL (1) IL87566A0 (fr)
PH (1) PH24568A (fr)
PT (1) PT88383B (fr)
ZA (1) ZA886459B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
TW438587B (en) 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
AU4050797A (en) * 1996-08-02 1998-02-25 Ligand Pharmaceuticals Incorporated Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
AU8588798A (en) * 1997-07-25 1999-02-16 Institut Pasteur Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor
FR2774591B1 (fr) * 1998-02-12 2000-05-05 Lipha Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
US7151191B2 (en) 2000-01-13 2006-12-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CN1332711C (zh) 2002-02-20 2007-08-22 埃米球科技有限公司 施用glp－1分子的方法
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
US20060286129A1 (en) * 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
EP1714648A4 (fr) * 2004-02-09 2010-05-26 Aska Pharm Co Ltd Medicament de combinaison
FR2898894B1 (fr) * 2006-03-24 2008-06-06 Genfit Sa Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
US10098860B2 (en) * 2016-07-20 2018-10-16 Cipla Limited Bezafibrate for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149070C3 (de) * 1971-10-01 1978-03-23 Boehringer Mannheim Gmbh, 6800 Mannheim Phenoxyalkylcarbonsäurederivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel
JPS56145261A (en) * 1980-04-10 1981-11-11 Kaken Pharmaceut Co Ltd Novel oxyacetic acid derivative, its preparation, and lowering agent of lipid in blood comprising it as active ingredient

Also Published As

Publication number Publication date
CA1323575C (fr) 1993-10-26
AU2158688A (en) 1989-05-25
DK472688D0 (da) 1988-08-24
KR890004690A (ko) 1989-05-09
AU610228B2 (en) 1991-05-16
ES2059457T3 (es) 1994-11-16
JP2647918B2 (ja) 1997-08-27
ATE95694T1 (de) 1993-10-15
ZA886459B (en) 1989-05-30
DE3729209A1 (de) 1989-03-09
EP0305890A3 (en) 1990-08-22
IE62189B1 (en) 1994-12-28
EP0305890B1 (fr) 1993-10-13
DE3884895D1 (de) 1993-11-18
PH24568A (en) 1990-08-03
US5304575A (en) 1994-04-19
HUT47427A (en) 1989-03-28
PT88383B (pt) 1992-10-30
EP0305890A2 (fr) 1989-03-08
IE882529L (en) 1989-03-01
PT88383A (pt) 1989-07-31
HU200687B (en) 1990-08-28
DE3729209C2 (fr) 1989-08-03
DK472688A (da) 1989-03-02
JPS6471813A (en) 1989-03-16

Similar Documents

Publication Publication Date Title
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
IL87566A0 (en) Medical composition for the treatment of diabetes comprising a benzamide derivative
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
ZA883115B (en) Treatment of diabetes
AU7064987A (en) Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfunctions
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
EP0430551A3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
ES2094757T3 (es) Un factor megacariocitopoyetico.
EP0212310A3 (en) Use of probucol in the preparation of a medicament for the treatment of heart arrhythmia
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
NZ226360A (en) Antiviral and antitumoural composition containing 2,6 diamino-3-phenyl-3-phenylazo-pyridine
PT82322A (en) Process for preparing cycloalkanecarboxanilides
GR3003065T3 (en) Use of n-((1-ethyl-2-pyrrolidinyl)methyl)-methoxy-5-sulfamoyl benzamide in the treatment of sterility
GR3004866T3 (fr)
GB8719741D0 (en) Regulating insulin treatment of diabetics
JO1516B1 (en) Compounds with cognitive effectiveness, factors containing them, and their use in treatment and disease prevention for cognitive dysfunction
GB8622419D0 (en) Treatment/therapy for diabetes sufferes
MTP1001B (en) Compounds having a cognition adjuvant action,agents containing them,and the use of there of for treatment and prophylaxis of cognitive dysfunctions (hoe 86/f069)